LncRNA ARGI Contributes to Virus-Induced Pancreatic β Cell Inflammation Through Transcriptional Activation of IFN-Stimulated Genes.


Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
09 2023
Historique:
revised: 30 05 2023
received: 04 01 2023
medline: 6 9 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Type 1 diabetes (T1D) is a complex autoimmune disease that develops in genetically susceptible individuals. Most T1D-associated single nucleotide polymorphisms (SNPs) are located in non-coding regions of the human genome. Interestingly, SNPs in long non-coding RNAs (lncRNAs) may result in the disruption of their secondary structure, affecting their function, and in turn, the expression of potentially pathogenic pathways. In the present work, the function of a virus-induced T1D-associated lncRNA named ARGI (Antiviral Response Gene Inducer) is characterized. Upon a viral insult, ARGI is upregulated in the nuclei of pancreatic β cells and binds to CTCF to interact with the promoter and enhancer regions of IFNβ and interferon-stimulated genes, promoting their transcriptional activation in an allele-specific manner. The presence of the T1D risk allele in ARGI induces a change in its secondary structure. Interestingly, the T1D risk genotype induces hyperactivation of type I IFN response in pancreatic β cells, an expression signature that is present in the pancreas of T1D patients. These data shed light on the molecular mechanisms by which T1D-related SNPs in lncRNAs influence pathogenesis at the pancreatic β cell level and opens the door for the development of therapeutic strategies based on lncRNA modulation to delay or avoid pancreatic β cell inflammation in T1D.

Identifiants

pubmed: 37382191
doi: 10.1002/advs.202300063
pmc: PMC10477904
doi:

Substances chimiques

RNA, Long Noncoding 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300063

Subventions

Organisme : European Foundation for the Study of Diabetes
ID : EFSD/JDRF/LillyProgrammeonType1DiabetesResearch
Organisme : Ministry of Science and Innovation, MCIN/AEI/10.13039/501100011033
ID : PID2019-104475GA-I00

Informations de copyright

© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

Virulence. 2020 Dec;11(1):68-79
pubmed: 31865850
Diabetes. 2014 Jul;63(7):2516-27
pubmed: 24608439
Cell Rep Med. 2021 Aug 17;2(8):100371
pubmed: 34467248
Diabetologia. 2021 Oct;64(10):2292-2305
pubmed: 34296320
Diabetologia. 2019 Mar;62(3):459-472
pubmed: 30478640
Cell Physiol Biochem. 2018;45(5):2031-2043
pubmed: 29529600
Diabetes. 2014 Feb;63(2):446-55
pubmed: 23974921
Front Cell Dev Biol. 2022 Aug 17;10:967765
pubmed: 36060810
Mediators Inflamm. 2016;2016:9275106
pubmed: 27698546
FEBS Lett. 2016 Aug;590(15):2342-53
pubmed: 27417130
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5115-20
pubmed: 17360338
Science. 2016 Apr 1;352(6281):91-5
pubmed: 27034373
Int J Mol Sci. 2019 Nov 25;20(23):
pubmed: 31775218
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):
pubmed: 34969862
J Biol Chem. 2011 Nov 11;286(45):39632-43
pubmed: 21937453
Cell. 2009 Jun 26;137(7):1194-211
pubmed: 19563753
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):
pubmed: 34426493
Science. 2013 Aug 16;341(6147):1237973
pubmed: 23828888
Annu Rev Genomics Hum Genet. 2013;14:325-53
pubmed: 23834318
Mol Metab. 2018 Feb;8:144-157
pubmed: 29307512
Adv Sci (Weinh). 2023 Sep;10(25):e2300063
pubmed: 37382191
Diabetes Obes Metab. 2013 Sep;15 Suppl 3:71-81
pubmed: 24003923
Cell. 2018 May 3;173(4):906-919.e13
pubmed: 29706547
Cell Rep. 2019 Jan 15;26(3):788-801.e6
pubmed: 30650367
Exp Mol Pathol. 2020 Jun;114:104432
pubmed: 32243891
Front Endocrinol (Lausanne). 2022 Jul 26;13:881997
pubmed: 35957810
Nat Commun. 2022 Oct 26;13(1):6363
pubmed: 36289205
FEBS J. 2019 May;286(9):1780-1795
pubmed: 30771271
Nucleic Acids Res. 2021 Jul 2;49(W1):W72-W79
pubmed: 34086933
Front Physiol. 2018 Aug 24;9:1201
pubmed: 30197605
Biomedicines. 2021 Oct 08;9(10):
pubmed: 34680532
J Cell Biol. 2021 Feb 1;220(2):
pubmed: 33464299
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9362-7
pubmed: 19474294
Nucleic Acids Res. 2018 Nov 2;46(19):10302-10318
pubmed: 30247717
J Exp Med. 1901 Mar 25;5(5):527-40
pubmed: 19866956
Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):9022-9031
pubmed: 32284404
J Clin Invest. 2011 Sep;121(9):3589-97
pubmed: 21865645
Diabetes. 2011 Dec;60(12):3279-88
pubmed: 21984578
Clin Exp Immunol. 1986 Jul;65(1):128-39
pubmed: 3098471
Philos Trans R Soc Lond B Biol Sci. 2013 May 06;368(1620):20120369
pubmed: 23650640
Genome Res. 2019 Feb;29(2):208-222
pubmed: 30587508
Nature. 2012 Feb 15;482(7385):339-46
pubmed: 22337053
Hum Mol Genet. 2010 Jan 1;19(1):135-46
pubmed: 19825843
Clin Exp Immunol. 2012 Apr;168(1):5-11
pubmed: 22385231
J Biol Chem. 2011 Jan 14;286(2):929-41
pubmed: 20980260
Nat Rev Endocrinol. 2009 Apr;5(4):219-26
pubmed: 19352320
Int J Biol Sci. 2020 Feb 10;16(7):1194-1206
pubmed: 32174794
Best Pract Res Clin Gastroenterol. 2015 Jun;29(3):425-35
pubmed: 26060107
Mamm Genome. 2022 Jun;33(2):343-353
pubmed: 34642784
Pharmacol Ther. 2020 Sep;213:107591
pubmed: 32473960
Nat Commun. 2020 Dec 11;11(1):6348
pubmed: 33311506
Diabetologia. 2016 Mar;59(3):512-21
pubmed: 26634571
Diabetologia. 2023 Jul;66(7):1306-1321
pubmed: 36995380
Nat Commun. 2017 Dec 11;8(1):2049
pubmed: 29230038
Diabetologia. 2019 Aug;62(8):1329-1336
pubmed: 31161346
Int J Mol Sci. 2019 Mar 14;20(6):
pubmed: 30875752
Science. 2013 Aug 16;341(6147):789-92
pubmed: 23907535
Diabetes. 2016 Oct;65(10):3104-10
pubmed: 27422384
Diabetologia. 2022 Dec;65(12):2108-2120
pubmed: 35953727
Clin Exp Immunol. 2012 Apr;168(1):12-23
pubmed: 22385232
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Diabetologia. 2015 Aug;58(8):1827-35
pubmed: 26037202
Biochim Biophys Acta Gene Regul Mech. 2020 Apr;1863(4):194419
pubmed: 31487549
Diabetes. 2015 May;64(5):1682-7
pubmed: 25422108
J Innate Immun. 2019;11(4):375-390
pubmed: 30799417
Diabetes. 2015 Nov;64(11):3808-17
pubmed: 26239055
PLoS One. 2014 Aug 21;9(8):e105723
pubmed: 25144376
Nat Rev Mol Cell Biol. 2018 Mar;19(3):143-157
pubmed: 29138516
Mol Cell. 2016 Feb 18;61(4):520-534
pubmed: 26853146
Sci Rep. 2016 Sep 01;6:32475
pubmed: 27582018
Eur J Endocrinol. 2021 Mar;184(3):455-468
pubmed: 33486469
Diabetes Res Clin Pract. 2003 Jan;59(1):51-61
pubmed: 12482642
Diabetes. 2008 Nov;57(11):2863-71
pubmed: 18971433
Diabetologia. 2013 Jan;56(1):185-93
pubmed: 23064357
Hum Mol Genet. 2008 Oct 15;17(R2):R116-21
pubmed: 18852199
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Lancet. 1987 Dec 19;2(8573):1423-7
pubmed: 2891993
Bioessays. 2020 Dec;42(12):e2000027
pubmed: 33164244

Auteurs

Itziar González-Moro (I)

Department of Biochemistry and Molecular Biology, University of the Basque Country, Leioa, 48940, Spain.
Biocruces Bizkaia Health Research Institute, Barakaldo, 48903, Spain.

Koldo Garcia-Etxebarria (K)

Biodonostia Health Research Institute, Gastrointestinal Genetics Group, San Sebastián, 20014, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, 08036, Spain.

Luis Manuel Mendoza (LM)

Department of Biochemistry and Molecular Biology, University of the Basque Country, Leioa, 48940, Spain.

Nora Fernández-Jiménez (N)

Biocruces Bizkaia Health Research Institute, Barakaldo, 48903, Spain.
Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, 48940, Spain.

Jon Mentxaka (J)

Department of Biochemistry and Molecular Biology, University of the Basque Country, Leioa, 48940, Spain.
Biocruces Bizkaia Health Research Institute, Barakaldo, 48903, Spain.

Ane Olazagoitia-Garmendia (A)

Department of Biochemistry and Molecular Biology, University of the Basque Country, Leioa, 48940, Spain.
Biocruces Bizkaia Health Research Institute, Barakaldo, 48903, Spain.

María Nicol Arroyo (MN)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Toshiaki Sawatani (T)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Cristina Moreno-Castro (C)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Chiara Vinci (C)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Anne Op de Beek (A)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Miriam Cnop (M)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.
Division of Endocrinology, Erasmus Hospital, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Mariana Igoillo-Esteve (M)

ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, 1070, Belgium.

Izortze Santin (I)

Department of Biochemistry and Molecular Biology, University of the Basque Country, Leioa, 48940, Spain.
Biocruces Bizkaia Health Research Institute, Barakaldo, 48903, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, 28029, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH